MORPHOGENESIS
Morphogenesis is a clinical-stage company that develops cell and gene therapies.
MORPHOGENESIS
Industry:
Biotechnology Genetics Health Care Medical Therapeutics
Founded:
1995-01-01
Address:
Tampa, Florida, United States
Country:
United States
Website Url:
http://www.morphogenesis-inc.com
Total Employee:
11+
Status:
Active
Contact:
(813) 875-6600
Total Funding:
25.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon GoDaddy DNS GoDaddy SSL GoDaddy Twitter Tweet Button GoDaddy CDN
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Board_member
Board_member
Current Employees Featured
Michael Lawson Owner & Founder @ Morphogenesis
Owner & Founder
Patricia Lawson Chief Executive Officer & Founder @ Morphogenesis
Chief Executive Officer & Founder
Founder
Investors List
KP Biotech Group
KP Biotech Group investment in Series A - Morphogenesis
Kiran Patel
Kiran Patel investment in Series A - Morphogenesis
Official Site Inspections
http://www.morphogenesis-inc.com Semrush global rank: 6.05 M Semrush visits lastest month: 1.35 K
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Morphogenesis"
Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA ...
Dec 14, 2023 SOURCE: Morphogenesis Inc. View the original press release on accesswire.com. 10500 University Center Drive Suite 110 Tampa FL 33612 813-875-6600 info@tuhurabio.com. …See details»
Morphogenesis - Crunchbase Company Profile
Organization. Morphogenesis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Legal Name …See details»
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger ...
May 23, 2023 Combined company will operate under the name “TuHURA Biosciences, Inc.” and advance a personalized cancer vaccine platform and preclinical tumor microenvironment …See details»
Morphogenesis Inc. | WebDisclosure
Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. and Provides a Business Overview. PRESS RELEASE. published on 11/08/2023 at 15:00, 1 year …See details»
Morphogenesis, Inc. - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. Morphogenesis, Inc. - BIO …See details»
Morphogenesis, Inc. Company Profile | Tampa, FL | Competitors ...
Find company research, competitor information, contact details & financial data for Morphogenesis, Inc. of Tampa, FL. Get the latest business insights from Dun & Bradstreet.See details»
Morphogenesis Company Profile - Craft
Morphogenesis is a clinical stage company specializing in cell and gene therapies. It develops ImmuneFx, cancer vaccine technology that focuses the power of the immune system on the …See details»
Morphogenesis Inc - Company Profile and News - Bloomberg …
Company profile page for Morphogenesis Inc including stock price, company news, executives, board members, and contact informationSee details»
Morphogenesis, Inc.:Company Profile & Technical …
Morphogenesis, Inc. is a company that provides Pharmacy and Therapeutics, Gene, Immunotherapy and more. Morphogenesis, Inc. is headquartered in United States . …See details»
Michael Lawman
Michael is a co-founder of Morphogenesis, Inc. Michael received his Ph.D. from the University of Surrey, UK, while working at the Animal Virus Research Institute (The Pirbright Institute). Michael came to the US as an NIH postdoctoral fellow …See details»
Morphogenesis, Inc. Announces Corporate Rebranding …
Dec 14, 2023 Morphogenesis Inc. Thu, Dec 14, 2023, 10:00 AM 5 min read. Company focused on advancing novel personalized cancer vaccines to overcome tumor resistance to immunotherapies like checkpoint ...See details»
Morphogenesis Company Profile | Management and Employees …
About Morphogenesis, Inc. - Morphogenesis, located in Tampa, FL, is developing targeted immunotherapies for the treatment of cancer. The Company's patented immunotherapy is …See details»
Morphogenesis, Inc. | CipherBio
Explore Morphogenesis, Inc.'s investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Morphogenesis, Inc. Is Developing a Cell and Gene Therapy …
Aug 2, 2019 Dr. Patricia Lawman, CEO and co-founder of UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, talks about the company, …See details»
Morphogenesis, Inc. Is Testing Cancer Vaccine - UF Innovate
Aug 7, 2019 Scientists at UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, call the “therapeutic vaccine” a simple and safe technology …See details»
EIN 59-3359711 - Morphogenesis Inc, Tampa, Florida - EIN TaxId
The employer identification number (EIN) for Morphogenesis Inc is 593359711. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply …See details»
Morphogenesis, Inc and the Cell and Gene Therapy Group at …
Sep 11, 2018 About Morphogenesis, Inc. - Morphogenesis, an emerging biotech company, is developing “off-the-shelf” personalized immunotherapies for the treatment of cancer. The …See details»
Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA …
Dec 14, 2023 TAMPA, FL / ACCESSWIRE / December 14, 2023 / Morphogenesis, Inc. (“Morphogenesis”), a Phase 3 registration-stage immuno-oncology company developing novel …See details»
CohBar (CWBR) and Morphogenesis, Inc. Enter into Definitive …
May 23, 2023 CohBar, Inc. (NASDAQ: CWBR) (CohBar or the company) and Morphogenesis, Inc. (Morphogenesis), a privately-held Phase 2/3 clinical-stage biotechnology company …See details»
Genetically encoded reporters of actin filament organization in …
Apr 2, 2025 These filaments perform a wide range of essential biological functions, such as muscle contraction, cell division, cell adhesion, cell motility, tissue morphogenesis, and …See details»